Invivyd Inc (IVVD)
2.40
-0.05
(-2.04%)
USD |
NASDAQ |
May 17, 16:00
2.40
0.00 (0.00%)
After-Hours: 20:00
Invivyd Cash from Investing (Quarterly): -0.14M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.14M |
| December 31, 2023 | 77.92M |
| September 30, 2023 | 95.14M |
| June 30, 2023 | 32.60M |
| March 31, 2023 | 75.04M |
| December 31, 2022 | -138.81M |
| September 30, 2022 | -140.84M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.017M |
| March 31, 2022 | 49.00M |
| December 31, 2021 | 137.92M |
| September 30, 2021 | -188.63M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-188.63M
Minimum
Sep 2021
137.92M
Maximum
Dec 2021
-0.0642M
Average
--
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | -18.22M |
| Viking Therapeutics Inc | -459.79M |
| Stoke Therapeutics Inc | 9.988M |
| 180 Life Sciences Corp | -- |
| MAIA Biotechnology Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -50.21M |
| Cash from Financing (Quarterly) | 39.10M |
| Free Cash Flow | -182.33M |
| Free Cash Flow Per Share (Quarterly) | -0.4355 |
| Free Cash Flow Yield | -68.30% |